Korean J Physiol Pharmacol.
1997 Feb;1(1):19-25.
Enhanced coupling of M-1 muscarinic receptors to activation of
phospholipase C upon mutation of a transposed amino acid triplet
repeat
- Affiliations
-
- 1
Department of Pharmacology, Catholic University Medical College, 505, Bampo-dong, Socho-ku, Seoul 137-701 South Korea.
Abstract
-
The C-terminus ends of the second putative transmembrane domains of
both M-1 and M-2 Muscarinic receptors contain a triplet of amino acid
residues consisting of leucine (L), tyrosine (Y) and threonine (T).
This triplet is repeated as LYT-TYL in M-1 receptors at the interface
between the second transmembrane domain and the first extracellular
loop. Interestingly, however, it is repeated in a transposed fashion
(LYT-LYT) in the sequence Of M-2 receptors. In our previous work, we
investigated the possible significance of this unique sequence
diversity for determining the distinct differential receptor function
at the two receptor subtypes. However, we found mutation of the LYTTYL
sequence of M-1 receptors to the corresponding M-2 receptor LYTLYT
sequence demonstrated markedly enhanced the stimulation of
phosphoinositide (PI) hydrolysis by carbachol without a change in its
coupling to increased cyclic AMP formation. In this work, thus, the
enhanced stimulation of PI hydrolysis in the LYTLYT M-1 receptor mutant
was further investigated. The stimulation of PI hydrolysis by carbachol
was enhanced in the mutant M-1 receptor, and this change was not due to
alterations in the rate of receptor desensitization or sequestration.
The observed larger response to carbachol at mutant M-1 receptors was
also not due to an artifact resulting from selection of CHO cells which
express higher levels of G-proteins or phospholipase C. Our data
suggest that although the LYTTYL sequence in M-1 muscarinic receptors
is not involved in determining receptor pharmacology, mutation of the
sequence enhanced the coupling of M-1 receptors to the stimulation of
phospholipase C.